罗格列酮和匹格列酮间无明显差别。
No difference between rosiglitazone and pioglitazone was apparent.
它的部分经费由吡格列酮的制造商武田制药提供。
It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
罗格列酮已经撤出欧洲市场，在美国的使用也被大大限制。
Rosiglitazone was taken off the market in Europe, and its use is greatly restricted in the United States.
应用推荐